Bryn Mawr Capital Management LLC Sells 67 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)

Bryn Mawr Capital Management LLC cut its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,809 shares of the medical research company’s stock after […]

Related Keywords

Canada ,United States ,Asia Pacific ,Jamesc Foster ,Birgit Girshick ,Advisor Group ,Charles River Laboratories International ,Securities Exchange Commission ,Raymond James Trust ,Citigroup ,Morgan Stanley ,Charles River Laboratories International Stock Down ,Bryn Mawr Capital Management ,Charles River Laboratories International Company Profile ,Charles River Laboratories International Inc ,Jpmorgan Chase Co ,Manufacturing Solutions ,Panagora Asset Management Inc ,Great West Life Assurance Co ,Commonwealth Of Pennsylvania Public School Empls Retrmt ,Quarter For Charles River Laboratories International ,Research Models ,Free Report ,Mawr Capital Management ,Asset Management ,Pennsylvania Public School Empls Retrmt ,West Life Assurance ,River Laboratories International Stock Down ,River Laboratories International ,Get Free Report ,Charles River Laboratories ,Safety Assessment ,Visit Holdingschannel ,Charles River Laboratories International Daily ,Nyse Crl ,Crl ,Medical ,15986410 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,